Business Wire

Real Time Location Systems (RTLS) Leader Sonitor® Technologies to partner with Hospital IT and Oslo Medtech to Host IT Solutions Symposium in Norway

Del

Sonitor Technologies, a global leader in real-time indoor positioning technologies, today announced that it will sponsor and participate in an international symposium on building sustainable public healthcare systems of the future. The symposium, hosted by Oslo Medtech (www.oslomedtech.no), a member organization that helps support the development of innovative medical technology and eHealth products and services for the Norwegian and global healthcare markets, will be held on May 24, 2016 at the Oslo Medtech premises in Gaustadalléen 21, 0349 Oslo, in the Forum meeting room.

Globally, healthcare systems face an array of increasing challenges, including meeting the needs of an aging global population and growing number of consumers requiring acute and chronic care. Climbing medical costs are also putting pressure on global healthcare systems, ultimately challenging them to provide sustainable levels of care. There is a growing understanding in the US healthcare market that technologies such as Sonitor’s real-time location systems (RTLS) can play a significant role in delivering operational intelligence. This insight can drive efficiencies that improve staff workflow, patient throughput, resource and asset management, and patient safety, all helping to address healthcare challenges today. During this symposium, representatives from European and United States healthcare facilities will share their knowledge and experience in applying innovative health IT solutions such as RTLS to deliver world-class and cost-effective care.

“There are a myriad of health IT applications making an impact on the healthcare system today, and RTLS is certainly one of them both clinically and operationally,” said Arne Øyen, Group President and CEO of Sonitor Technologies. “With a reliable, highly accurate RTLS hardware backbone, hospitals, long term care facilities, and their patients worldwide are benefitting from a growing list of highly productive applications which run on it including asset management, patient and staff workflow, duress and safety, and environmental monitoring to name a few. In this symposium we’ll discuss how RTLS is being used today and how it will enable healthcare system of the future to function efficiently to best serve its patients and stakeholders.”

Success of these applications requires strong integration between the RTLS and best-in-breed software solutions. Hospital IT, led by CEO Flemming Hegerstrøm, delivers a software platform that integrates with Sonitor’s open integration RTLS to automate and streamline processes. This workflow optimization and process improvement ultimately helps European healthcare facilities accelerate on-boarding of new staff, increase productivity and efficiency and free caregiver time to focus on delivering better, faster care. Hospital IT’s SmartSolution platform is seamlessly integrated with leading electronic medical records systems for long term healthcare and hospital facilities.

“We are very excited to welcome such esteemed hospitals and users to our forum, and to hear more about how the innovative technology of our member companies Sonitor and Hospital IT improve operational efficiency, quality and patient experience in US hospitals and elsewhere,” said Kathrine Myhre, CEO of Oslo Medtech. “Part of innovating is sharing ideas and experiences, between US and Norwegian hospitals, companies and users, and we are so pleased to provide a platform for this.”

About Sonitor Technologies

Sonitor Technologies’ tiered resolution Real Time Location Systems (RTLS), with patented High Definition Ultrasound capabilities, are specifically developed and designed for indoor positioning in complex environments. Sonitor has developed the healthcare industry’s most advanced open integration RTLS platform, Sonitor Sense™, a wireless system which supports a wide range of applications to make hospital operations more efficient. Sonitor is selected by world-class partners to build industry-leading solutions for global deployment. For more information please visit www.sonitor.com.

Contact information

Beacon Communications
Dan Conley
312-593-8461
dconley@beaconpr.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom